Contract Would Represent First International Order of TPOXX  Canadian Military Intends Firm Delivery of 2,500 Courses, with Additional Option Quantities of 12,825 Courses NEW YORK , Dec. 05, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical

NEW YORK , Nov. 18, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that the Canadian Department of National Defence (CDND) has issued an advanced contract award notice

NEW YORK , Oct. 21, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Phillip L. Gomez , Chief Executive Officer, will be a speaker at the Non-Conventional Threats

NEW YORK , Oct. 03, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has reached concurrence with the US Food and Drug Administration ( FDA ) that no further clinical

NEW YORK , Sept. 26, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Phillip L. Gomez , SIGA’s Chief Executive Officer, will present at the Cantor Fitzgerald Global

NEW YORK , Sept. 25, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Dennis E. Hruby , the Company’s Chief Scientific Officer, will be a speaker at the 13 th

NEW YORK , Aug. 28, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Phillip L. Gomez , SIGA’s Chief Executive Officer, will participate in an analyst-led fireside

NEW YORK , July 08, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that it has been awarded a multi-year contract from the United States Department of Defense (DoD) to

NEW YORK , June 18, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (NASDAQ: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr. Phillip L. Gomez , Chief Executive Officer, will be a speaker at the Non-Conventional Threats

NEW YORK , June 11, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. ( SIGA ) (Nasdaq: SIGA ), a commercial-stage pharmaceutical company focused on the health security market, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M.